Table 1.
Criteria to evaluate the quality of included studies
Quality items | Signaling questions |
---|---|
Type of cohort study | Does the study have a prospective or retrospective design? |
Method of patient selection | Was a consecutive, randomly selected, or obviously representative series of patients included? |
Patient spectrum | Were selection criteria for CTPA reported? |
Blinded assessment of outcome | Were CTPA interpreters blinded to clinical information (i.e., study purpose or COVID-19 status of patients)? |